Drugs and Biologicals, Coverage of, for Label and Off-Label Uses
J6 · Effective Oct 1, 2015
6 active Medicare policies list J3315, and 13 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JJ · Effective Feb 19, 2023
JM · Effective Feb 19, 2023
J6 · Effective Apr 1, 2026
National · Effective Oct 1, 2025
13 policies from 13 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of J3315 |
|---|---|---|
| Benign Prostatic Hyperplasia | Feb 8, 2024 | Covered |
| Policy | Effective | Status of J3315 |
|---|---|---|
| Triptorelin (e.g., Triptodur, Trelstar) | Not recorded | Covered with conditionsInferred from policy title |
| Policy | Effective | Status of J3315 |
|---|---|---|
| Oncology Medications | Jul 1, 2026 | Covered |
| Policy | Effective | Status of J3315 |
|---|---|---|
| Oncology Medications | Jul 1, 2026 | Covered |
| Policy | Effective | Status of J3315 |
|---|---|---|
| Oncology Medications | Jul 1, 2026 | Covered |
| Policy | Effective | Status of J3315 |
|---|---|---|
| Oncology Medications | Jul 1, 2026 | Covered |
| Policy | Effective | Status of J3315 |
|---|---|---|
| Triptorelin Pamoate (Trelstar) | Dec 1, 2016 | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3315 |
|---|---|---|
| Cigna MedOnc Master Drug List.pdf | Not recorded | Prior auth required |
| Policy | Effective | Status of J3315 |
|---|---|---|
| Triptorelin pamoate (Trelstar, Triptodur); CP.PHAR.175 | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3315 |
|---|---|---|
| Q4 - 2026 JHP MedOnc Master Drug List.pdf | Not recorded | Prior auth required |
| Policy | Effective | Status of J3315 |
|---|---|---|
| Gonadotropin Releasing Hormone Analogs | Jul 1, 2025 | Covered |
| Policy | Effective | Status of J3315 |
|---|---|---|
| Gonadotropin Releasing Hormone Analogs | Jul 1, 2025 | Covered |
| Policy | Effective | Status of J3315 |
|---|---|---|
| Gonadotropin Releasing Hormone Analogs | Jul 1, 2025 | Covered |